KRMD vs. LUNA

Last updated Apr 2, 2026

Compare and contrast key facts about Repro Med Systems, Inc. (KRMD) and Luna Innovations Incorporated (LUNA).

Performance

KRMD vs. LUNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Repro Med Systems, Inc. (KRMD) and Luna Innovations Incorporated (LUNA). The values are adjusted to include any dividend payments, if applicable.

KRMD vs. LUNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
KRMD Repro Med Systems, Inc.	-26.51%	50.91%	56.82%	-31.23%	19.00%	-50.17%	-7.81%	295.76%	32.00%	150.00%
LUNA Luna Innovations Incorporated	3.48%	-46.76%	-67.52%	-24.35%	4.15%	-14.57%	35.53%	117.61%	37.86%	65.31%

Fundamentals

Total Revenue (TTM) KRMD : $41.13M LUNA : $116.61M
Gross Profit (TTM) KRMD : $25.60M LUNA : $68.80M
EBITDA (TTM) KRMD : -$1.85M LUNA : $7.02M

Returns By Period

In the year-to-date period, KRMD achieves a -26.51% return, which is significantly lower than LUNA's 3.48% return. Over the past 10 years, KRMD has outperformed LUNA with an annualized return of 28.80%, while LUNA has yielded a comparatively lower 1.07% annualized return.

KRMD

• 1D: -1.16%
• 1M: -12.32%
• YTD: -26.51%
• 6M: 12.07%
• 1Y: 70.12%
• 3Y*: 0.39%
• 5Y*: 3.59%
• 10Y*: 28.80%

LUNA

• 1D: 8.18%
• 1M: -19.05%
• YTD: 3.48%
• 6M: 8.18%
• 1Y: 112.50%
• 3Y*: -45.10%
• 5Y*: -35.70%
• 10Y*: 1.07%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

KRMD vs. LUNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KRMD

KRMD Risk / Return Rank: 76
KRMD Sharpe Ratio Rank: 77
KRMD Sortino Ratio Rank: 80
KRMD Omega Ratio Rank: 73
KRMD Calmar Ratio Rank: 75
KRMD Martin Ratio Rank: 75

LUNA

LUNA Risk / Return Rank: 74
LUNA Sharpe Ratio Rank: 63
LUNA Sortino Ratio Rank: 80
LUNA Omega Ratio Rank: 87
LUNA Calmar Ratio Rank: 70
LUNA Martin Ratio Rank: 69

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KRMD vs. LUNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Repro Med Systems, Inc. (KRMD) and Luna Innovations Incorporated (LUNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	KRMD	LUNA	Difference
Sharpe ratio Return per unit of total volatility	1.18	0.63	+0.55
Sortino ratio Return per unit of downside risk	2.14	2.14	0.00
Omega ratio Gain probability vs. loss probability	1.24	1.36	-0.12
Calmar ratio Return relative to maximum drawdown	1.92	1.50	+0.42
Martin ratio Return relative to average drawdown	4.71	3.58	+1.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

KRMD vs. LUNA - Sharpe Ratio Comparison

The current KRMD Sharpe Ratio is 1.18, which is higher than the LUNA Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of KRMD and LUNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	KRMD	LUNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.18	0.63	+0.55
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.06	-0.33	+0.39
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.41	0.01	+0.39
Sharpe Ratio (All Time) Calculated using the full available price history	0.09	-0.08	+0.17

Correlation

The correlation between KRMD and LUNA is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

KRMD vs. LUNA - Dividend Comparison

Neither KRMD nor LUNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

KRMD vs. LUNA - Drawdown Comparison

The maximum KRMD drawdown since its inception was -97.69%, roughly equal to the maximum LUNA drawdown of -97.65%. Use the drawdown chart below to compare losses from any high point for KRMD and LUNA.

Drawdown Indicators

	KRMD	LUNA	Difference
Max Drawdown Largest peak-to-trough decline	-97.69%	-97.65%	-0.04%
Max Drawdown (1Y) Largest decline over 1 year	-35.43%	-50.00%	+14.57%
Max Drawdown (5Y) Largest decline over 5 years	-59.29%	-97.65%	+38.36%
Max Drawdown (10Y) Largest decline over 10 years	-84.30%	-97.65%	+13.35%
Current Drawdown Current decline from peak	-65.62%	-90.70%	+25.08%
Average Drawdown Average peak-to-trough decline	-59.09%	-64.99%	+5.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.45%	20.94%	-6.49%

Volatility

KRMD vs. LUNA - Volatility Comparison

The current volatility for Repro Med Systems, Inc. (KRMD) is 10.19%, while Luna Innovations Incorporated (LUNA) has a volatility of 21.79%. This indicates that KRMD experiences smaller price fluctuations and is considered to be less risky than LUNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KRMD	LUNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.19%	21.79%	-11.60%
Volatility (6M) Calculated over the trailing 6-month period	36.00%	78.15%	-42.15%
Volatility (1Y) Calculated over the trailing 1-year period	59.77%	181.35%	-121.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	61.31%	107.33%	-46.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	71.07%	85.24%	-14.17%

Financials